Gilead Sciences, Inc. (GILD)
Gilead Sciences Market Cap : 188.19B for Feb. 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 202.57B |
| Johnson & Johnson | 574.79B |
| Eli Lilly & Co. | 937.35B |
| Merck & Co., Inc. | 291.81B |
| Regeneron Pharmaceuticals, Inc. | 82.50B |
Market Cap Related Metrics
| PE Ratio | 23.49 |
| PS Ratio | 6.561 |
| PEG Ratio | 0.0033 |
| Price to Book Value | 8.737 |
| Price to Free Cash Flow | 20.81 |
| Price | 151.68 |
| Earnings Yield | 4.26% |
| PEGY Ratio | 0.0033 |
| Operating PE Ratio | 16.81 |
| Normalized PE Ratio | 21.94 |